BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 21120602)

  • 1. Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2.
    Paruthiyil S; Cvoro A; Tagliaferri M; Cohen I; Shtivelman E; Leitman DC
    Breast Cancer Res Treat; 2011 Oct; 129(3):777-84. PubMed ID: 21120602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle.
    Lin CC; Lin SY; Chung JG; Lin JP; Chen GW; Kao ST
    Anticancer Res; 2006; 26(2A):1097-104. PubMed ID: 16619512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O; Lattrich C; Springwald A; Ortmann O
    Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physalis angulata induced G2/M phase arrest in human breast cancer cells.
    Hsieh WT; Huang KY; Lin HY; Chung JG
    Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F; Giuliano AE; Law RE; Van Herle AJ
    Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
    Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
    Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
    Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
    Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the cdc-2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein.
    Touny LH; Banerjee PP
    Prostate; 2006 Oct; 66(14):1542-55. PubMed ID: 16924665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for Wee1 in inhibition of G2-to-M transition through the cooperation of distinct human papillomavirus type 1 E4 proteins.
    Knight GL; Turnell AS; Roberts S
    J Virol; 2006 Aug; 80(15):7416-26. PubMed ID: 16840322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrate-Induced p85α⁻PTEN Complex Formation Causes G
    Hung KC; Wang SG; Lin ML; Chen SS
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
    Donato LJ; Suh JH; Noy N
    Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induction of G2 /M phase arrest and apoptosis of MCF-7 cells by novel benzofuran lignan via suppressing cell cycle proteins].
    Yang H; Cai YC; Pang JY; Li YQ; Zeng ZL; Xu ZL; Xian LJ
    Yao Xue Xue Bao; 2008 Feb; 43(2):138-44. PubMed ID: 18507339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
    Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
    Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.
    Choi EJ; Kim GH
    J Nutr Biochem; 2009 Apr; 20(4):285-90. PubMed ID: 18656338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells.
    Barascu A; Besson P; Le Floch O; Bougnoux P; Jourdan ML
    Int J Biochem Cell Biol; 2006 Feb; 38(2):196-208. PubMed ID: 16194618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Severe Fever with Thrombocytopenia Syndrome Virus NSs Protein Interacts with CDK1 To Induce G
    Liu S; Liu H; Kang J; Xu L; Zhang K; Li X; Hou W; Wang Z; Wang T
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.
    Kawakubo H; Brachtel E; Hayashida T; Yeo G; Kish J; Muzikansky A; Walden PD; Maheswaran S
    Cancer Res; 2006 Jul; 66(14):7075-82. PubMed ID: 16849553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
    Park M; Chae HD; Yun J; Jung M; Kim YS; Kim SH; Han MH; Shin DY
    Cancer Res; 2000 Feb; 60(3):542-5. PubMed ID: 10676633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.